Ikarian Capital, LLC

13F Holdings History for Channel Therapeutics Corp - Common Stock, par value $0.0001 per share (CHRO)

Symbol: CHRO
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 441K shares
Security Ownership: 7.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Ikarian Capital, LLC ownership in Channel Therapeutics Corp Common Stock, par value $0.0001 per share (CHRO)

2025-02-14 - Ikarian Capital, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 441K shares of Channel Therapeutics Corp Common Stock, par value $0.0001 per share (CHRO). This represents 7.3% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Ikarian Capital, LLC	7.3%		$595K	441K			$1.35	13G	12/31/2024	14 Feb 2025 13:09:03

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025			-0.2%	$0	0	-440,849	-100%		Q2 2025
3/31/2025		0.2%	+0.2%	$626K	441K	+440,849	NEW	$1.42	Q1 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.